PCSK9 and diabetes mellitus: On the other hand, recent studies demonstrated that loss-of-function variants in PCSK9 were associated with lower LDL-C levels but associated with increased levels of fasting glucose concentration and an increased risk for new-onset diabetes, which resulted in serious concerns about the safety of the anti-PCSK9 treatments [11–13].